Top Stock Movers Now: Jabil, Norwegian Cruise Line, Hims & Hers Health, and More

By
Aaron McDade
Aaron McDade Headshot
Full Bio
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like the war in Ukraine for respected outlets like Business Insider and Newsweek.
Learn about our editorial policies
Published May 20, 2024
Tourists visit Junkanoo Beach as a Norwegian Cruise Line ship departs Nassau, Bahamas, on April 29, 2024

Scott McIntyre / Bloomberg via Getty Images

Key Takeaways

  • Tech sector gains helped power the Nasdaq to a record intraday high on Monday, May 20, 2024, while the S&P 500 was also higher. 
  • Cruise stocks were among the biggest gainers in the S&P 500, led by Norwegian Cruise line after the cruise operator raised its full-year guidance amid strong demand.
  • Shares of Hims & Hers Health skyrocketed after the company announced plans to start offering access to GLP-1 injections as part of its weight-loss prescriptions.

Tech sector gains helped power the Nasdaq to a record intraday high on Monday, while the S&P 500 was also higher. The Dow, however, was lower.

Norwegian Cruise Line Holdings (NCLH) led gains on the S&P 500, with shares surging after the company announced a new long-term strategy, along with updated 2026 financial targets and raised its guidance for fiscal 2024 amid strong demand. Other cruise stocks also rose, including Carnival (CCL) and Royal Caribbean Cruises (RCL).

Engineering and manufacturing company Jabil (JBL) gained after the company announced the permanent CEO appointment of Michael Dastoor, who had been operating as CFO and interim CEO. Other executive changes were announced as well, as the company completed an investigation into its corporate policies.

Shares of telehealth company Hims & Hers Health (HIMS) skyrocketed after it announced plans to start offering access to popular GLP-1 injections as part of its weight-loss prescriptions.

"Providing access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic and Wegovy without navigating the shortages and costs that are currently limiting access to the branded medications," the company said.

NCLH

TradingView
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.

  1. Norwegian Cruise Line Holdings. "Norwegian Cruise Line Holdings Ltd. Announces “Charting the Course” Strategy and New 2026 Financial Targets; Increases Full Year 2024 Guidance."

  2. Business Wire. "Jabil Announces Leadership Transitions."

  3. Hims & Hers Health. "Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers."

Take the Next Step to Invest
×
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.